商品名或批准名。第三部分。特殊情况。抗风湿药物。
Trade names or approved names. Part III. Special cases. Anti-rheumatic drugs.
作者信息
Currey H L
出版信息
Postgrad Med J. 1974 Feb;50(580):109-11. doi: 10.1136/pgmj.50.580.109.
Abstract
Prescription of anti-rheumatic drugs should be by approved name because in most cases differences in absorption can be compensated by titration of dosage against effectiveness and toxicity. There are a few instances, for example phenylbutazone, where known differences of bio-availability justify the use of a particular brand.
摘要
抗风湿药物的处方应以通用名开具，因为在大多数情况下，吸收差异可通过根据疗效和毒性调整剂量来弥补。有少数情况，例如保泰松，已知的生物利用度差异使得使用特定品牌是合理的。
相似文献
1
Trade names or approved names. Part III. Special cases. Anti-rheumatic drugs.商品名或批准名。第三部分。特殊情况。抗风湿药物。
Postgrad Med J. 1974 Feb;50(580):109-11. doi: 10.1136/pgmj.50.580.109.
2
Trade names or approved names. Part III. Special cases. Antibiotics.商品名或批准名。第三部分。特殊情况。抗生素。
Postgrad Med J. 1974 Feb;50(580):96-7. doi: 10.1136/pgmj.50.580.96.
3
Trade names or approved names. Part III. Special cases. Anti-diabetic drugs.商品名或批准名。第三部分。特殊情况。抗糖尿病药物。
Postgrad Med J. 1974 Feb;50(580):112-3. doi: 10.1136/pgmj.50.580.112.
4
Trade names or approved names. Part III. Special cases. The digoxin affair.商品名或批准名。第三部分。特殊情况。地高辛事件。
Postgrad Med J. 1974 Feb;50(580):98-102. doi: 10.1136/pgmj.50.580.98.
5
Trade names or approved names. Part III. Special cases. Combination products.商品名或批准名。第三部分。特殊情况。组合产品。
Postgrad Med J. 1974 Feb;50(580):103-6. doi: 10.1136/pgmj.50.580.103.
6
Trade names or approved names. Part IV. The solution. Introduction.商品名或批准名。第四部分。解决方案。引言。
Postgrad Med J. 1974 Feb;50(580):121. doi: 10.1136/pgmj.50.580.121.
7
Trade names or approved names. Part 11. Points of view. The general practitioner.商品名或批准名。第11部分。观点。全科医生。
Postgrad Med J. 1974 Feb;50(580):88-90. doi: 10.1136/pgmj.50.580.88.
8
Trade names or approved names. Part 1. The situation Substitution: right or wrong?商品名或批准名。第1部分。情况 替换：对还是错？
Postgrad Med J. 1974 Feb;50(580):68-70. doi: 10.1136/pgmj.50.580.68.
9
Trade names or approved names. Part II. Points of view. The retail pharmacist.商品名或批准名。第二部分。观点。零售药剂师。
Postgrad Med J. 1974 Feb;50(580):81-2. doi: 10.1136/pgmj.50.580.81.
10
Trade names or approved names. Part II. Points of view. The department of health.商品名或批准名。第二部分。观点。卫生部。
Postgrad Med J. 1974 Feb;50(580):77-80. doi: 10.1136/pgmj.50.580.77.
本文引用的文献
1
The absorption characteristics of paracetamol tablets in man.对乙酰氨基酚片在人体中的吸收特性。
J Pharm Pharmacol. 1963 Jul;15:445-53. doi: 10.1111/j.2042-7158.1963.tb12812.x.
2
The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets.固体剂型的生物药剂学性质。I. 对23个品牌保泰松片的评价
Can Med Assoc J. 1967 Jun 10;96(23):1513-20.
3
Scientific principles in design of drug dosage formulations.药物剂型设计中的科学原理。
Br Med J. 1972 Jan 8;1(5792):102-6. doi: 10.1136/bmj.1.5792.102.
Zotero 插件